ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Pediatric Endocrinology
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1518746
Manuscript length: The article contains 3299 characters, 4 tables and 3 figures
Provisionally accepted- 1Children‘s Hospital of Chongqing Medical University, Chongqing, China
- 2Chongqing Health Center for Women and Children, Chongqing, Chongqing, China
- 3Chengdu Women and Children’s Central Hospital, Chengdu, Sichuan Province, China
- 4Chongqing Three Gorges Central Hospital, Chongqing, China
- 5First People’s Hospital of Zunyi, Zunyi, Guizhou Province, China
- 6Kunming Children's Hospital, Kunming, Yunnan Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The available evidence on tight glycemic control is conflicting, while the interaction between glucose and lactate in critically ill children remains unclear.Objective: To explore the potential role of hyperlactatemia (HL) in modulating the relationship between stress hyperglycemia (SHG) and poor outcomes, aiming to establish tailored glucose targets in critically ill children.This was a secondary analysis of a prospective observational cohort study conducted in five Pediatric Intensive Care Units (PICU) in southwestern China (ChiCTR2000030846). The interaction effect between glucose and lactate metrics concerning outcomes and subsequent subgroup regression analysis was conducted. SHG was defined as glucose > 150 mg/dL(8.3mmol/L) and HL as lactate > 2 mmol/L.A cohort of 433 pediatric patients with 4885 arterial blood gas measurements were finally enrolled. 90 (20.8%) cases died within 28 days of PICU admission. Significant interaction effects between SHG and HL on outcomes were observed (p < 0.05). In the non-HL group, SHG was not an independent predictor of 28-day mortality (p = 0.656) and was not correlated with either 28-day ventilator-free days (p = 0.916) or 28-day ICU-free days (p = 0.914). In contrast, in the HL group, SHG was independently associated with 28-day mortality (OR 3.55, 95% CI 1.62~7.80, p = 0.002) and correlated with a reduction of 5.04 28day ventilator-free days (p = 0.003) and 4.10 28-day ICU-free days (p = 0.004).Conclusions: HL potentially modulates the correlation between SHG and poor outcomes in pediatric critically ill patients. Combined SHG and HL are associated with poor outcomes, whereas SHG without HL is not.
Keywords: Critically ill, Children, Hyperlactatemia, stress hyperglycemia, Outcome
Received: 28 Oct 2024; Accepted: 30 May 2025.
Copyright: © 2025 Liu, Milan, Li, Zhang, Chen, Jiang, Duan, Xiong, Huang, Zou, Liu, Fu and Yu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jing Li, Children‘s Hospital of Chongqing Medical University, Chongqing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.